Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8926 |
High Similarity |
NPD7819 |
Suspended |
0.8741 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8732 |
High Similarity |
NPD2796 |
Approved |
0.8543 |
High Similarity |
NPD7411 |
Suspended |
0.8446 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8431 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8414 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8414 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8403 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8389 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8389 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8389 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8377 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8356 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8355 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8312 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8299 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8269 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8258 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8247 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8228 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8165 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8158 |
Intermediate Similarity |
NPD920 |
Approved |
0.8146 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8121 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8112 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8054 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8038 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8027 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8026 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7987 |
Intermediate Similarity |
NPD919 |
Approved |
0.7975 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7935 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7927 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7925 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7885 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7853 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7853 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7848 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7843 |
Intermediate Similarity |
NPD1511 |
Approved |
0.784 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.784 |
Intermediate Similarity |
NPD5711 |
Approved |
0.784 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7823 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7806 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7805 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7792 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7792 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7763 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7763 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7762 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7762 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7742 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7733 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7733 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7733 |
Intermediate Similarity |
NPD6100 |
Approved |
0.773 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD17 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7697 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7665 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7651 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7633 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7574 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7574 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7564 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7552 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD6651 |
Approved |
0.753 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7518 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7515 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7467 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7467 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7455 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7397 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7383 |
Intermediate Similarity |
NPD411 |
Approved |
0.7383 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7361 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7351 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7351 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7347 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7338 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7288 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7279 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7262 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7261 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7241 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7239 |
Intermediate Similarity |
NPD37 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7212 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7212 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7203 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7198 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7184 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD943 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7095 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7079 |
Intermediate Similarity |
NPD4287 |
Approved |
0.707 |
Intermediate Similarity |
NPD2897 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7062 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7055 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7051 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7051 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7039 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD5585 |
Approved |
0.703 |
Intermediate Similarity |
NPD6279 |
Approved |
0.703 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7017 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7017 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7006
|
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |